These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 24884703)
1. Role of inflammation in previously untreated macular edema with branch retinal vein occlusion. Noma H; Mimura T; Shimada K BMC Ophthalmol; 2014 May; 14():67. PubMed ID: 24884703 [TBL] [Abstract][Full Text] [Related]
2. Association of inflammatory factors with macular edema in branch retinal vein occlusion. Noma H; Mimura T; Eguchi S JAMA Ophthalmol; 2013 Feb; 131(2):160-5. PubMed ID: 23411880 [TBL] [Abstract][Full Text] [Related]
3. Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion. Noma H; Funatsu H; Mimura T; Eguchi S; Hori S Am J Ophthalmol; 2011 Oct; 152(4):669-677.e1. PubMed ID: 21726846 [TBL] [Abstract][Full Text] [Related]
4. Pentraxin 3 and other inflammatory factors in central retinal vein occlusion and macular edema. Noma H; Mimura T; Masahara H; Shimada K Retina; 2014 Feb; 34(2):352-9. PubMed ID: 23842103 [TBL] [Abstract][Full Text] [Related]
5. Aqueous flare and inflammatory factors in macular edema with central retinal vein occlusion: a case series. Noma H; Mimura T; Tatsugawa M; Shimada K BMC Ophthalmol; 2013 Dec; 13():78. PubMed ID: 24325604 [TBL] [Abstract][Full Text] [Related]
6. Vitreous inflammatory factors in macular edema with central retinal vein occlusion. Noma H; Funatsu H; Harino S; Mimura T; Eguchi S; Hori S Jpn J Ophthalmol; 2011 May; 55(3):248-255. PubMed ID: 21538003 [TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema. Noma H; Funatsu H; Mimura T; Harino S; Eguchi S; Hori S Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1559-65. PubMed ID: 20714746 [TBL] [Abstract][Full Text] [Related]
8. Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema. Noma H; Mimura T; Yasuda K; Shimura M Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3878-85. PubMed ID: 24894397 [TBL] [Abstract][Full Text] [Related]
9. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Noma H; Funatsu H; Mimura T; Harino S; Hori S Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700 [TBL] [Abstract][Full Text] [Related]
10. Role of inflammation in diabetic macular edema. Noma H; Mimura T; Yasuda K; Shimura M Ophthalmologica; 2014; 232(3):127-35. PubMed ID: 25342084 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Noma H; Minamoto A; Funatsu H; Tsukamoto H; Nakano K; Yamashita H; Mishima HK Graefes Arch Clin Exp Ophthalmol; 2006 Mar; 244(3):309-15. PubMed ID: 16133018 [TBL] [Abstract][Full Text] [Related]
13. Association of electroretinographic parameters and inflammatory factors in branch retinal vein occlusion with macular oedema. Noma H; Funatsu H; Mimura T Br J Ophthalmol; 2012 Dec; 96(12):1489-93. PubMed ID: 23077221 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Jian K; Sakamoto I; Nakano K; Yamashita H; Minamoto A; Mishima HK Am J Ophthalmol; 2005 Aug; 140(2):256-61. PubMed ID: 16086947 [TBL] [Abstract][Full Text] [Related]
15. Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion. Noma H; Funatsu H; Mimura T; Harino S; Hori S Eur J Ophthalmol; 2010; 20(2):402-9. PubMed ID: 19967679 [TBL] [Abstract][Full Text] [Related]
16. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion. Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978 [TBL] [Abstract][Full Text] [Related]
17. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema. Noma H; Mimura T; Yasuda K; Shimura M Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159 [TBL] [Abstract][Full Text] [Related]
18. Aqueous Angiopoietin-Like 4 Levels Correlate With Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion. Kim JH; Shin JP; Kim IT; Park DH Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):6-11. PubMed ID: 26746013 [TBL] [Abstract][Full Text] [Related]
19. Vitreous inflammatory factors and serous macular detachment in branch retinal vein occlusion. Noma H; Funatsu H; Mimura T; Tatsugawa M; Shimada K; Eguchi S Retina; 2012 Jan; 32(1):86-91. PubMed ID: 21866074 [TBL] [Abstract][Full Text] [Related]
20. Association between macular microcirculation and soluble intercellular adhesion molecule-1 in patients with macular edema and retinal vein occlusion. Noma H; Funatsu H; Sakata K; Mimura T; Hori S Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1515-8. PubMed ID: 20309574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]